Valuation Result
Final Brand Value

Apoteket — Retail

Valuation date: 10/29/2026

Total Brand Value
SEK 1.0B
This result turns the selected legal, brand, benchmark and discount-rate assumptions into one reviewable brand value estimate.
Brand Strength
76/100
Royalty Rate
0.5%
Discount Rate
9.7%
Benchmark recommendation not unlocked for this result
Sensitivity snapshot

Quick decision check for discount rate, royalty rate and long-term growth.

WACC (Discount Rate)
9.7%
-1.0%
SEK 1.1B
9.7%
SEK 1.0B
+1.0%
SEK 896.4M
Royalty Rate
0.5%
-0.5%
N/A
0.5%
SEK 1.0B
+0.5%
SEK 2.1B
Terminal Growth
1.5%
-0.5%
SEK 958.7M
1.5%
SEK 1.0B
+0.5%
SEK 1.0B
Brand Strength changes can also be explored to show their potential effect on brand value. Contact info@brandvaluator.se if you want to explore this for strategy, planning and budgeting.
Revenue Base
SEK 21.2B
Legal Protection
74/100
Long-term Growth
1.5%
Recommendation basis
Brand-strength range • Pro
This reference case derives its royalty rate by applying the brand-strength score to a documented industry royalty ceiling.
This valuation uses benchmark support informed by external market references and curated internal calibration.
Use this section to confirm whether the result reflects unlocked benchmark guidance or a non-benchmark method.
Forecast profile
5 years explicit forecast
High growth: 2.0%
Base growth: 1.5%
Long-term growth: 1.5%
Value build
Value for planning period: SEK 322.9M
Terminal value: SEK 677.7M
How the valuation is built

Valuation Build

Royalty Relief DCF
YearRevenueRoyaltyAfter TaxPV
Y1SEK 21,574,020,000SEK 98,377,531SEK 78,111,760SEK 74,561,425
Y2SEK 22,005,500,400SEK 100,345,082SEK 79,673,995SEK 69,296,280
Y3SEK 22,445,610,408SEK 102,351,983SEK 81,267,475SEK 64,402,932
Y4SEK 22,782,294,564SEK 103,887,263SEK 82,486,487SEK 59,561,720
Y5SEK 23,124,028,983SEK 105,445,572SEK 83,723,784SEK 55,084,426
Explicit PV (Y1–Y5)SEK 322,906,783
Terminal Value (undiscounted)SEK 1,030,058,752
Terminal PV (discounted)SEK 677,707,002
Total Brand ValueSEK 1,000,613,785

Supporting context

This section explains the evidence and judgment used to support the recommendation and the legal, brand and financial assumptions used in the valuation.

Reference case

Apoteket

Prepared reference case

Indicative estimate of approximately SEK 1.00bn for the Apoteket name in consumer pharmacy retail. Reported FY2025 consumer sales are an exposure proxy, not revenue caused by the name. Component scores, royalty and forecast are analyst judgments.

Scope and capacity: the estimate covers consumer pharmacy retail, not dos and healthcare contracts or Apoteket AB as a whole. The opening hypothetical royalty of SEK 96.4m equals 17.1% of FY2025 group EBIT. Because that EBIT includes activities outside the selected consumer sales base, this is a directional 25%-rule check rather than a matched segment-profit test. Regulated medicine prices, product mix, store operations and professional service also contribute to sales. Legal component scores are outside-in judgments, not a legal opinion.
Informed by numerous sources including company reporting, investor materials, analyst research, market data and selected benchmark references where relevant.
Key inputs
Reported = directly sourced • Estimated = selected judgment • Inferred = derived from broader evidence • Assumed = inclusion choice
Revenue perimeter
SEK 21.151bnreported
Brand strength
76/100estimated
Royalty and 25% check
0.456%; SEK 96.4m opening royaltyestimated
Legal and rate
74/100; 9.75%estimated
Forecast and external check
2% for three years, then 1.5%; terminal 1.5%assumed
Company disclosures

These links lead to company-issued materials. BrandValuator cross-checks indicative estimates against multiple sources; the final assumptions and judgments are our own. Each input is labeled by evidence status above.

Legal Protection

trademark Status78
scope Of Rights74
risk Profile65
litigation70
contractual Rights72
goodwill Evidence82
regulatory Compliance75

Brand Strength

marketing Investment72
quality78
availability92
distinctive Brand Codes83
mental Availability90
consideration78
trust82
choice Share77
penetration81
price Elasticity57
revenue Premium51
margin Premium50
stability74